Immediate Impact
1 from Science/Nature 66 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Guangyu Ding being referenced
Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approach
2020
Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Guangyu Ding | 119 | 145 | 122 | 226 | 158 | 31 | 597 | |
| Yoshiyuki Nishikawa | 97 | 111 | 123 | 469 | 129 | 28 | 739 | |
| Chung‐Wai Shiau | 49 | 81 | 70 | 256 | 179 | 33 | 589 | |
| Jian Wang | 120 | 187 | 45 | 202 | 142 | 38 | 733 | |
| Qifan Zhang | 100 | 176 | 154 | 302 | 111 | 42 | 700 | |
| Dengke Zhang | 57 | 160 | 145 | 279 | 188 | 37 | 712 | |
| Masakazu Yasumaru | 195 | 61 | 97 | 156 | 125 | 31 | 711 | |
| Yan Li | 88 | 183 | 34 | 307 | 134 | 33 | 664 | |
| Ester Gonzalez‐Sanchez | 101 | 90 | 109 | 241 | 175 | 25 | 572 | |
| Yu-Feng Yan | 153 | 122 | 63 | 269 | 109 | 23 | 712 | |
| Wenliang Tan | 119 | 160 | 121 | 230 | 150 | 32 | 526 |
All Works
Login with ORCID to disown or claim papers
Loading papers...